ABL Bio Inc (298380) — Working Capital to Net Assets Ratio
ABL Bio Inc (298380) has a Working Capital to Net Assets ratio of 40.7% as of June 2026. Working capital of ₩70.85 Billion (current assets of ₩169.87 Billion minus current liabilities of ₩99.02 Billion) is measured against net assets of ₩173.94 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See ABL Bio Inc (298380) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ABL Bio Inc Working Capital to Net Assets (2016–2025)
This chart shows how ABL Bio Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 40.7%, reflecting working capital of ₩70.85 Billion against net assets of ₩173.94 Billion KRW. For the complete balance sheet picture, see ABL Bio Inc total assets.
Annual Working Capital to Net Assets for ABL Bio Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ABL Bio Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check ABL Bio Inc (298380) asset resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 33.5% | ₩52.55 Billion | ₩156.70 Billion | ₩176.05 Billion | ₩123.50 Billion | ▼ -14.8 pp |
| 2024 | 48.3% | ₩80.79 Billion | ₩167.28 Billion | ₩144.15 Billion | ₩63.36 Billion | ▲ +2.7 pp |
| 2023 | 45.6% | ₩33.78 Billion | ₩74.08 Billion | ₩75.54 Billion | ₩41.76 Billion | ▲ +33.6 pp |
| 2022 | 12.0% | ₩8.36 Billion | ₩69.51 Billion | ₩80.53 Billion | ₩72.17 Billion | ▼ -53.6 pp |
| 2021 | 65.6% | ₩36.72 Billion | ₩55.95 Billion | ₩45.47 Billion | ₩8.75 Billion | ▼ -4.9 pp |
| 2020 | 70.5% | ₩63.95 Billion | ₩90.66 Billion | ₩71.92 Billion | ₩7.97 Billion | ▼ -24.4 pp |
| 2019 | 94.9% | ₩125.33 Billion | ₩132.01 Billion | ₩134.66 Billion | ₩9.33 Billion | ▼ -0.3 pp |
| 2018 | 95.2% | ₩149.50 Billion | ₩156.96 Billion | ₩161.09 Billion | ₩11.59 Billion | ▲ +104.7 pp |
| 2017 | -9.4% | ₩8.09 Billion | ₩-85.96 Billion | ₩9.44 Billion | ₩1.34 Billion | ▲ +35.1 pp |
| 2016 | -44.6% | ₩5.39 Billion | ₩-12.10 Billion | ₩5.69 Billion | ₩303.04 Million | — |